(Q34819036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sebastian Klammt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Silke C Mueller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Jolanta Majcher-Peszynska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Ralf G Mundkowski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Hartwig Sievers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Romanus Lehnfeld

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Bruno Frank

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kerstin Thurow

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Guenther Kundt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Bernd Drewelow

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

3 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

81-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

Role of hyperforin in the pharmacological activities of St. John's Wort.

13 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-008-0554-Y

The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.

21 January 2018

1 reference

12 December 2020

Comparison of German St. John's wort products according to hyperforin and total hypericin content.

1 reference

12 December 2020

Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.

1 reference

12 December 2020

Hyperforin in St. John's wort drug interactions

1 reference

12 December 2020

St. John's wort: role of active compounds for its mechanism of action and efficacy

1 reference

12 December 2020

Drug interaction studies: study design, data analysis, and implications for dosing and labeling

1 reference

12 December 2020

Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.

1 reference

12 December 2020

Drug interactions with St John's wort : mechanisms and clinical implications

1 reference

12 December 2020

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

1 reference

12 December 2020

The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials

1 reference

12 December 2020

Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo

1 reference

12 December 2020

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

1 reference

12 December 2020

Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures

1 reference

12 December 2020

St John's wort, a herbal antidepressant, activates the steroid X receptor.

1 reference

12 December 2020

In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs

1 reference

12 December 2020

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

1 reference

12 December 2020

Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.

1 reference

12 December 2020

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

1 reference

12 December 2020

No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract

1 reference

12 December 2020

Mechanism of action of St John's wort in depression : what is known?

1 reference

12 December 2020

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

1 reference

12 December 2020

Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail

1 reference

12 December 2020

Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations

1 reference

12 December 2020

Determining hyperforin and hypericin content in eight brands of St. John's wort.

1 reference

12 December 2020

10.1007/S00228-008-0554-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762932%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 January 2020

1051918922

0 references

1 reference